Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Featured Articles

Cannabis ETFs Evolve but Don’t Yet Excel

Cannabis ETFs Evolve but Don’t Yet Excel

The first cannabis exchange-traded fund (ETF) launched in 2017, and we have been following the developments closely since then. Today, we are tracking 11 ETFs. We recently shared a review of these funds with subscribers to our premium cannabis due diligence service...

read more

Featured Articles

NORML’s Federal Marijuana Lobbyist Departs After Five Years Advancing Reform On Capitol Hill

NORML’s Federal Marijuana Lobbyist Departs After Five Years Advancing Reform On Capitol Hill

When it comes to advocating for marijuana reform on Capitol Hill, Justin Strekal of NORML is one of the most widely recognized faces of the movement, putting in the hours to champion the cause of cannabis consumers and convince lawmakers to get on board. But after five years, the chapter of his career as NORML’s political director has come to a close. While he will continue to work to advance the cause in a different capacity, NORML will be getting a new lobbyist to fight for an end to federal cannabis prohibition in Congress. Paradoxically, Strekal personally thinks that professional lobbying should be abolished. But in his years as the federal lobbyist for NORML, he’s demonstrated how having a voice directly whispering—and, occasionally, shouting—in the ears of policymakers and their staff can help affect real change. “I took the responsibility of being the federal lobbyist and political director for NORML incredibly seriously as a way to harness the decades and decades of organizing that has been done by activists in as pointed and tenacious a way as possible to translate that into federal policy reform,” Strekal told Marijuana Moment.

Kyle Jaeger, Marijuana Moment, 01/06/2022 09:06:00

Open article: https://www.marijuanamoment.net/normls-federal-marijuana-lobbyist-departs-after-five-years-advancing-reform-on-capitol-hill/

read more
Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation

Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation

The GOP-controlled New Hampshire House of Representatives on Thursday approved a bill to legalize marijuana possession and personal cultivation for adults. Members passed the legislation, sponsored by Rep. Carol McGuire (R), in a 241-113 vote. This comes one day after the chamber narrowly rejected a separate, broader legalization proposal that would have regulated commercial production and sales. The approved measure that is now advancing to the Senate will not allow cannabis commerce, but adults 21 and older would be allowed to possess and give away up to three-fourths of an ounce of marijuana and grow up to six plants, three of which could be mature. The bill is virtually identical to an earlier version that also passed the House under Democratic control in 2020. The previous bill died in the Senate committee. “It is not—and never has been—the job of government to try to protect you from hurting yourself,” Rep. Max Abramson (R) said ahead of Thursday’s vote. “And outside of the 1950s B horror movies, it has never been the job of government to protect you from a plant.” Under the measure, there are penalties for public consumption, violating restrictions on home cultivation such as by growing in a publicly visible space and extracting cannabis in a dangerous manner. “This is truly a bipartisan issue with strong and wide support from Granite Staters,” Rep. Mark Warden (R) said. “The war on cannabis is a war on people. Those people are our neighbors and our constituents.” New Hampshire lawmakers have had their pick of marijuana reform legislation, with at least six new cannabis legalization proposals having been recently filed for the 2022 session. On Wednesday, the chamber defeated one bill that would have established a retail market for adult-use cannabis.

Kyle Jaeger, Marijuana Moment, 01/06/2022 11:17:00

Open article: https://www.marijuanamoment.net/gop-controlled-new-hampshire-house-votes-to-legalize-marijuana-possession-and-cultivation/

read more
How Accessibility Is Destroying The Legal Marijuana Industry In America

How Accessibility Is Destroying The Legal Marijuana Industry In America

Interesting story out of California last week where the marijuana industry is sending an SOS letter to the state government saying their legal industry is on the verge of collapse. The gist of the story is that higher taxes, not enough locations, too many fees, and too many consumers going to the illicit market are causing a financial firestorm for legal marijuana businesses. The most striking line of the article out there is that 73% of cannabis transactions occur on the illicit market in California, and not the licensed, legal one. This is bad for legal businesses. No taxes are paid on illegal sales, no revenue is created to pay for those state marijuana licenses, no 280E tax code relief, and a whole lot of fees for software, banking, and technology. The state has pledged $100 million to help figure out the legal cannabis industry. But that just tells half the story of why the cannabis industry may have just hit its first maturity point as an industry as a whole. For consumers it was never about legalization; it was about accessibility.

Terry Hacienda, The Fresh Toast, 01/05/2022 13:13:00

Open article: https://thefreshtoast.com/cannabusiness/how-accessibility-is-destroying-the-legal-marijuana-industry-in-america/#utm_source=rss&utm_medium=rss&utm_campaign=how-accessibility-is-destroying-the-legal-marijuana-industry-in-america

read more
New York Gov. Kathy Hochul: $200 Million Cannabis Equity Fund Will “Create Opportunities”

New York Gov. Kathy Hochul: $200 Million Cannabis Equity Fund Will “Create Opportunities”

As state regulators gear up to launch what will be one of the country’s biggest legal cannabis markets, New York Gov. Kathy Hochul put equity in the spotlight with a new $200 million fund. In her State of the State speech on Wednesday, Hochul outlined sweeping budget priorities from climate action to education. While neither cannabis or hemp came up during Hochul’s speech, Hochul included in her far-reaching budget plan a $200 million public-private equity fund to “promote equity and economic justice in New York’s cannabis industry.” The seed money will come from licensing fees and tax revenue, according to the State of the State book, and the fund will also “leverage significant private investment.” While estimates vary, New York’s cannabis industry is expected to top $4 billion. Access to capital is a major hurdle for many cannabis industry hopefuls, especially those who seek to qualify as equity applicants. The state defines equity applicants a bit differently than other states by including distressed farmers and women and veteran-owned businesses, for example, along with applicants that come from communities affected by disproportionate enforcement of cannabis laws.

Alyson Martin, Cannabis Wire, 01/04/2022 19:00:00

Open article: https://cannabiswire.com/2022/01/05/new-york-gov-kathy-hochul-says-200-million-cannabis-equity-fund-will-create-opportunities/

read more
Is Big Pharma Weed Coming With Pfizer’s Recent Purchase?

Is Big Pharma Weed Coming With Pfizer’s Recent Purchase?

Pfizer wants in on the cannabis game. Will you be buying Pharma Weed? Most consumers say absolutely not. You may not have heard the wonderful news. Our great overlords and global saviors at Pfizer announced their intentions to get into the medical cannabis market via their $6.7 billion acquisition of Arena Pharmaceuticals Inc. Of course, the giant pharmaceutical company has a lot of “expendable cash” available due to the pandemic. However, the news of Pfizer wanting to break into the medical cannabis industry isn’t something new. Every advocate understood that once cannabis is legalized globally, these giant pharmaceutical companies would definitely make their claim to some portion of the marketplace. Whether this is a “good” thing or a “bad” thing is irrelevant; the truth of the matter is that pharma entering into the cannabis industry is an inevitability. Putting my personal prejudices aside for a moment, along with some of the more atrocious historical facts of the company, perhaps this could be the dawn of the next wave of cannabinoid medicines. While some might cringe at the idea of pharma handling this sacred plant, cannabinoid-based medicines will evolve into more standardized packaging. It will eventually become dose-specific and potentially a robust cannabinoid treatment protocol for a large group of conditions. For that to happen, pharma has to dig their money-hungry hands into the market and begin to do some R&D. In the case of their recent acquisition, we can already see that they are targeting specific conditions and will be creating a medication instead of trying to sell tinctures, whole plant, etc.

420 Intel – Marijuana Industry News, 01/05/2022 19:00:00

Open article: https://420intel.com/articles/2022/01/06/big-pharma-weed-coming-pfizer%E2%80%99s-recent-purchase

read more
$200M Cannabis and Marijuana Lending Fund Established by the StandardC Network

$200M Cannabis and Marijuana Lending Fund Established by the StandardC Network

StandardC, a leader in cannabis & marijuana banking and financial services, announced today that its lending partner had closed the first $5 million loan from their newly established $200M fund for a leading marijuana cultivator using the StandardC platform.  This partner has extensive experience in the cannabis lending industry, facilitating real estate loans and deploying growth capital for companies like Harborside, Caliva, and other multi-state operators (MSOs).  While most lenders have been reticent to serve the state-licensed cannabis industry, StandardC’s lending network has broken new ground to offer cost-effective financing. These new credit facilities have expanded the capacity of the StandardC network, which can now provide enhanced banking services to over 1,500 cannabis and marijuana businesses through its network. Robert Mann, CEO of StandardC, was quoted as saying, “For too long, the cannabis industry has been unable to obtain loans and lines of credit without paying a ‘Cannabis Tax’ where lenders charge exorbitant interest and fees. Our network is enabling a consortium of lenders that can offer cost-effective real estate loans, lines of credit, and more.” Robert Baron, CXO of StandardC, commented, “While it was previously thought that lending for the state-licensed cannabis industry carried far too much inherent risk, StandardC’s proprietary pre-qualification and monitoring technology helps lenders ensure that the cannabis businesses are operating in compliance with state law and federal banking guidelines, thus providing that lender with greater assurance on the security of its loans and lines of credit for marijuana-related businesses.”

420 Intel – Marijuana Industry News, 01/04/2022 19:00:00

Open article: https://420intel.com/articles/2022/01/05/200m-cannabis-and-marijuana-lending-fund-established-standardc-network

read more

Join Our Mailing List

Older Posts

All Categories

Production

Consumer

Pharma

Events and Networking

Dispensaries

Politics and Law

Sales and Operations

Investors

View all categories

The Indica Perspective

Always the latest news you need.

Indica News brings you all the latest information from the cannabis world. Sign up today for the latest news.

Advertisement

Indica News

(833) 769-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM